Tamtam Try Tamtam free
Beth Israel Lahey Health logo

Beth Israel Lahey Health account plan

Comprehensive patient care network

At a glance

Beth Israel Lahey Health is a Massachusetts non-profit health system with $9.7 billion of FY2025 operating revenue and 39,000 employees.

Beth Israel Lahey Health (BILH) is a non-profit health system formed in 2019 from the CareGroup, Lahey and Seacoast systems, and calls itself the second largest health care system in New England, spanning Cape Cod to Southern New Hampshire. It runs an academic medical center (Beth Israel Deaconess Medical Center), teaching hospitals including Lahey and Mount Auburn, the orthopedic New England Baptist Hospital, community hospitals, a behavioral health hospital and physician organisations, and serves more than 2.1 million patients with 39,000 employees and 5,300 physicians. In the fiscal year ended September 30, 2025, total operating revenues were $9,679,967k and income from operations was $93,304k, its first operating gain in four years, after a loss of $(248,951)k in FY2024. Medicare is the largest payer. Kevin Tabb is President and CEO until Peter Shorett takes over in January 2027.

Business units

Strategic priorities

Blueprint 2030: care in the community
Shift care from BIDMC and Lahey to community settings: 64 percent of care is delivered there today, against about half in 2019, with 70 percent targeted by 2030. Outpatient visits rose 11 percent in the last fiscal year.
Primary care as the front door
New primary care providers grew 30 percent over four fiscal years, and 60 primary care clinicians joined last year, 20 of them from Mass General Brigham.
Cancer partnership with Dana-Farber
A 10-story, 300-bed inpatient cancer hospital on the former Joslin site, connected to BIDMC and scheduled to open in 2031; final state approval came on May 19, 2025.
Operating as one system
Supplies, equipment and services are managed as one system, some services were consolidated, and about 600 people were laid off in late 2024.
Single IT platform
The Epic electronic medical record roll-out across BILH entities, started in FY2024, was substantially completed by September 30, 2025, with Workday funded by the same bonds.

Latest results

In the fiscal year ended September 30, 2025, total operating revenues rose to $9,679,967k from $8,907,184k and patient service revenue grew 7 percent to $7.6 billion. Income from operations swung to $93,304k from a loss of $(248,951)k, and investment gains lifted the excess of revenues over expenses to $376,173k. Cash flow from operations was $443,988k. In the state's HFY 2025 comparison, BILH's operating margin was 0.9% and total margin 3.8%, against a system median total margin of 4.7%.

Investments and deals

Series N and O bonds
In August 2025 BILH issued $893,100k of tax-exempt Series N bonds, funding its share of the Dana-Farber Cancer Facility and other capital projects, and $130,580k of taxable Series O bonds.
Epic and Workday systems
Funded in part by the 2023 Series M bonds ($400,000k); the Epic roll-out was substantially complete by September 30, 2025.
Capital spending
Purchases of property and equipment were $322,002k in FY2025, with construction in progress of $199,037k.
New community sites
An urgent care centre in Haverhill, a large clinic in Middleborough and a Quincy clinic due in 2027.

Challenges and risks

Public payer dependence
Medicare reimbursement fell short of cost by $490,750k and Medicaid and other low-income programmes by $308,735k in FY2025; federal Medicaid changes and the One Big Beautiful Bill Act add strain.
Loss-making hospitals and physician groups
Anna Jaques, Milton and New England Baptist ran operating losses in HFY 2025, and Lahey Clinic posted the largest physician-organisation loss in the state, $103.1M.
End of the state price cap
BILH is leaving a seven-year state price cap imposed as a merger condition, but CEO Kevin Tabb says persuading insurers to pay more is harder.
Research funding and compliance
The audit names possible cuts to clinical research funding as a risk and reported one significant deficiency on NIH grant cost allowability at BIDMC and Joslin.
Ageing plant and leadership transition
Average age of plant is 17 years, and a new CEO takes over in January 2027 while the cancer hospital project proceeds.

What leadership says

“It's a short-sighted view to say we can't afford to invest in primary care. I take the opposite view. We can't afford not to.”

Kevin Tabb, President and CEO · Boston Globe, January 24, 2026

“Things will get more difficult, not less, in health care in general.”

Kevin Tabb, President and CEO · Boston Globe, January 24, 2026

“I've built my entire career off of really working collaboratively with physician leaders, bringing their voices to the table, and leveraging their expertise.”

Peter Shorett, Senior EVP and COO (CEO from January 2027) · Boston Globe, October 8, 2026, on his appointment as CEO

Where a supplier can help

Community and outpatient expansion
Tied to the Blueprint 2030 priority and new community sites: clinic fit-out, imaging and urgent care equipment, scheduling and patient access tools.
Revenue cycle and payer contracting
Tied to the public payer and price cap challenges: revenue cycle, coding and payer analytics that support negotiations with insurers.
Physician group performance
Tied to the loss-making physician organisations: practice management, staffing and productivity tools for employed physician groups.
Systemwide procurement and Epic optimisation
Tied to the one-system priority and the completed Epic roll-out: group purchasing, supply chain and Epic-integrated applications.
Cancer hospital construction
Tied to the Dana-Farber partnership: construction, medical equipment and IT for the 300-bed cancer hospital opening in 2031.

Tamtam's reading of the priorities and challenges above, not the company's own words.

Selling to companies like Beth Israel Lahey Health?

Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.

Find similar companies

Key documents

Read in full by Tamtam; each summary links to the document itself.

Questions about Beth Israel Lahey Health

What is Beth Israel Lahey Health?

A Massachusetts non-profit health system formed in 2019 that runs Beth Israel Deaconess Medical Center, Lahey, Mount Auburn, New England Baptist, community hospitals and physician organisations across Eastern Massachusetts and southern New Hampshire.

What is Beth Israel Lahey Health's revenue?

Total operating revenues were $9,679,967k in the fiscal year ended September 30, 2025, with income from operations of $93,304k.

How many employees does Beth Israel Lahey Health have?

39,000 employees and 5,300 physicians, per a spokesperson in October 2026.

Who leads Beth Israel Lahey Health?

Dr. Kevin Tabb is President and CEO; Peter Shorett, Senior EVP and COO, becomes CEO in January 2027.

What is Beth Israel Lahey Health's strategy?

Blueprint 2030 moves care to community settings, with 70 percent targeted by 2030, invests in primary care, runs the hospitals as one system, and builds a cancer hospital with Dana-Farber.

Written by Tamtam from the company's own published documents listed above, read in full. Figures are as those documents state them, for the periods they name. (2026-11-17)